Get the content you want anytime you want.

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

Health Care Providers Are the Gatekeepers of PrEP
Colleen Kelley, MD, describes the role of health care providers in linking patients with PrEP.
Classes and Agents Available to Treat <i>Pseudomonas</i> Infections
Peter L. Salgo, MD; Andrew Shorr, MD; Jason Pogue, PharmD, BCPS-AQID; and Marin Hristos Kollef, MD, consider the respective value of fluoroquinolones, polymyxins, and aminoglycosides as drug classes used to treat certain cases of Pseudomonas infections.
What Motivates Outpatient Providers to Write Unnecessary Prescriptions For Antibiotics?
Mike Kohut, PhD shares the results of his research that reveals providers are writing prescriptions for infections based largely on patient demand and not guideline recommendations.
What Makes <em>Elizabethkingia</em> Unique?
Emil Lesho, DO, FACP, FIDSA, FSHEA, explains what makes Elizabethkingia unique.
How to Create Institution-Specific Antibiotic Stewardship Interventions
Contagion® Editorial Advisory Board member, James S. Lewis, PharmD, FIDSA, shares how antibiotic stewards can craft stewardship interventions to their own reality.
Fighting <i>Pseudomonas</i>: Impact On Patient Prognosis & Approaches to Combat Infection
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; Marin Hristos Kollef, MD; and Yoav Golan, MD, reflect on the impact that Pseudomonas infections have on patients’ prognoses and outline the basic treatment approaches they take to combat these infections.
Long-Acting Injectable ART: Benefits & Misconceptions
Joseph Eron, MD, discusses benefits of long-acting injectable antiretroviral therapy as well as misconceptions.
MDR Infections: Overview of Antimicrobial Stewardships
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Debra Goff, PharmD, FCCP; and Sandy J. Estrada Lopez, PharmD, BCPS (AQID), outline the function of antimicrobial stewardships regarding multidrug-resistant bacterial infections and emphasize the importance of personnel at all levels within this system.
Big advances in treatment can